These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. Fyhrquist F; Metsärinne K; Tikkanen I J Hum Hypertens; 1995 Nov; 9 Suppl 5():S19-24. PubMed ID: 8583476 [TBL] [Abstract][Full Text] [Related]
25. Role for endothelin-1 in angiotensin II-mediated hypertension. Rajagopalan S; Laursen JB; Borthayre A; Kurz S; Keiser J; Haleen S; Giaid A; Harrison DG Hypertension; 1997 Jul; 30(1 Pt 1):29-34. PubMed ID: 9231817 [TBL] [Abstract][Full Text] [Related]
26. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Li Q; Dale WE; Hasser EM; Blaine EH Am J Physiol; 1996 Jul; 271(1 Pt 2):R200-7. PubMed ID: 8760221 [TBL] [Abstract][Full Text] [Related]
27. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II. Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857 [TBL] [Abstract][Full Text] [Related]
28. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Kabour A; Henegar JR; Devineni VR; Janicki JS Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449 [TBL] [Abstract][Full Text] [Related]
29. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects. Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799 [TBL] [Abstract][Full Text] [Related]
30. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. Ramsay LE; Yeo WW J Hum Hypertens; 1995 Nov; 9 Suppl 5():S51-4. PubMed ID: 8583482 [TBL] [Abstract][Full Text] [Related]
31. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines. Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897 [TBL] [Abstract][Full Text] [Related]
32. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats. Noll G; Lang MG; Tschudi MR; Ganten D; Lüscher TF Am J Physiol; 1997 Jan; 272(1 Pt 2):H493-500. PubMed ID: 9038972 [TBL] [Abstract][Full Text] [Related]
33. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment. Willemsen JM; Rabelink TJ; Boer P; Gaillard CA J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886 [TBL] [Abstract][Full Text] [Related]
34. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet. Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314 [TBL] [Abstract][Full Text] [Related]
35. Actions of angiotensin and lisinopril on thalamic somatosensory neurons in normotensive, non-transgenic and hypertensive, transgenic rats. Albrecht D; Henklein P; Ganten D J Hypertens; 1997 Oct; 15(10):1151-7. PubMed ID: 9350589 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Rajagopalan S; Kurz S; Münzel T; Tarpey M; Freeman BA; Griendling KK; Harrison DG J Clin Invest; 1996 Apr; 97(8):1916-23. PubMed ID: 8621776 [TBL] [Abstract][Full Text] [Related]
37. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats. Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin II: nitric oxide interaction and the distribution of blood flow. Sigmon DH; Beierwaltes WH Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267 [TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343 [TBL] [Abstract][Full Text] [Related]
40. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II. Barrett RJ; Droppleman DA Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]